Teladoc Health (TDOC) Receivables (2014 - 2026)

Teladoc Health has disclosed Receivables across 13 years of filings, most recently posting $222.5 million for Q1 2026.

• Receivables for Q1 2026 came in at $222.5 million, down 8.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $222.5 million (down 8.51% YoY), and the FY2025 annual result was $201.7 million, down 9.96% from the prior year.
• Receivables came in at $222.5 million for Q1 2026 at Teladoc Health, up from $201.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $243.2 million in Q1 2025 to a low of $201.7 million in Q4 2025.
• The 5-year median for Receivables is $227.3 million (2022), against an average of $226.3 million.
• Across the five-year window, Receivables advanced 27.01% in 2022 and declined 9.96% in 2025, its largest moves.
• Teladoc Health's Receivables stood at $235.6 million in 2022, then fell by 2.37% to $230.1 million in 2023, then fell by 2.65% to $224.0 million in 2024, then slipped by 9.96% to $201.7 million in 2025, then advanced by 10.35% to $222.5 million in 2026.
• The last three Receivables figures came in at $222.5 million (Q1 2026), $201.7 million (Q4 2025), and $219.5 million (Q3 2025), per Business Quant data.